Below is a graphic overview of VytlOne’s integrated approach to optimizing a health system’s pharmacy services, savings and revenue. In 340B support alone, we’ve generated over $500 million for the hospitals we serve — revenue those systems have used to positively impact the quality and scope of patient care they offer, in countless ways. Why … Read More
It’s no secret that the 340B Drug Pricing Program has been a lifeline for eligible health systems, enabling them to fill-in the massive revenue gaps inherent to the non-profit-hospital business model (and, in the process, support their mission of providing quality care to our nation’s most vulnerable patients) through access to discounted prescription refills. At … Read More
Randy Bell’s last pharmacy job was so disheartening, he left his chosen profession for seven years. And that’s not the half of it. It was a full year before his next career move — residential real estate — started generating positive income flow. So yes, you could say it’s a bit of an understatement when … Read More
Based on our experience, it’s a claim we can make with 100% certainty. VytlOne has supported the 340B programs of more than 100 health systems and health centers since 2019. Altogether, we’ve generated nearly $1 billion in pharmacy-related savings for our clients. While the average 340B hospital’s revenues have decreased significantly since the 2020 advent … Read More
In late 2022, VytlOne’s team initiated 340B Program-Management support for a 198-bed, full-service, community and regional non-profit medical center located in the Northeast. After weeks of laying all the necessary groundwork to manage its 340B program, we began actively submitting eligible prescriptions this past January. By the end of Q1, the hospital’s 2023 340B savings … Read More
Why 340B vendors charging Percentage Of Revenue is wrong. From time to time, 340B hospitals are required to purchase non-eligible prescriptions at the Wholesale Acquisition Cost. When that happens, the costs of those medications often exceed reimbursement. Most 340B hospitals already operate on a loss-basis. Which is why, we believe, it’s so wrong for 340B … Read More
Shandra Bouzemann did not start working with VytlOne’s Pharmacy At DeSoto by choice. “I was a senior at Ole Miss in 2021, and we were asked to choose the pharmacy where we’d like to do rotations. Well naturally, I picked the one at Baptist Oxford, which was a three-minute drive from campus, and less than … Read More
To date, we’ve published a dozen posts either detailing, or mentioning-in-passing, the clinical and financial benefits a well-run Meds To Beds program offers hospitals and the patients they serve. Which is why we thought it was time to report some of the personal benefits our program delivers — with a handful of stories we’ve heard … Read More
Since the advent of 340B ESP in 2020, drug manufacturers have imposed a raft of unlawful restrictions on 340B program savings. Nowhere have those restrictions been more punitive than with specialty pharmacy medications; drugs which typically represent the most expensive (and profitable) in manufacturers’ product lines. 340B restrictions from the drug manufacturers’ perspective That said, … Read More
Just ask her, she’ll admit it: When Shequila worked at VytlOne’s Conway Medical Center (CMC) pharmacy, her boss had a habit of talking about her to other people in the company. Which explains why she got an email one day from Dawn Dobersztyn, asking, “Have you seen this job opening we just posted?” Seems that … Read More
